$4.37
00.00%
Last update: 4:00 PM
15 minutes delayed
scPharmaceuticals
SCPHNASDAQ
want to know what
the Bulls & Bears Say?
scPharmaceuticals (NASDAQ:SCPH) Stock, Analyst Ratings, Price Targets, Forecasts
scPharmaceuticals Inc has a consensus price target of $18.33 based on the ratings of 19 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Craig-Hallum on May 15, 2024, March 14, 2024, and September 7, 2023, respectively. With an average price target of $18.67 between HC Wainwright & Co., HC Wainwright & Co., and Craig-Hallum, there's an implied 336.14% upside for scPharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Craig-Hallum
Maxim Group
SVB Leerink
Cowen & Co.
1calculated from analyst ratings
Analyst Ratings for scPharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 09/07/2023 | Buy Now | 367.29% | Craig-Hallum | Chase Knickerbocker | → $20 | Initiates | → Buy | Get Alert |
| 08/11/2023 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2023 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 367.29% | Maxim Group | Naz Rahman | $13 → $20 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 03/23/2023 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | → Buy | Get Alert |
| 01/27/2023 | Buy Now | 203.74% | SVB Leerink | Roanna Ruiz | $12 → $13 | Maintains | Outperform | Get Alert |
| 12/01/2022 | Buy Now | 484.11% | Cowen & Co. | Ken Cacciatore | → $25 | Initiates | → Outperform | Get Alert |
| 11/10/2022 | Buy Now | 320.56% | HC Wainwright & Co. | Douglas Tsao | $15 → $18 | Maintains | Buy | Get Alert |
| 11/10/2022 | Buy Now | 180.37% | SVB Leerink | Roanna Ruiz | $11 → $12 | Maintains | Outperform | Get Alert |
| 10/21/2022 | Buy Now | 227.1% | Jefferies | Glen Santangelo | → $14 | Assumes | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 157.01% | SVB Leerink | Roanna Ruiz | $6 → $11 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/02/2022 | Buy Now | — | Maxim Group | Naz Rahman | — | Initiates | → Buy | Get Alert |
| 05/17/2022 | Buy Now | 40.19% | SVB Leerink | Roanna Ruiz | $5 → $6 | Maintains | Market Perform | Get Alert |
| 09/09/2021 | Buy Now | 40.19% | SVB Leerink | Roanna Ruiz | — | Initiates | → Market Perform | Get Alert |
FAQ
What is the target price for scPharmaceuticals (SCPH) stock?
The latest price target for scPharmaceuticals (NASDAQ:SCPH) was reported by HC Wainwright & Co. on May 15, 2024. The analyst firm set a price target for $18.00 expecting SCPH to rise to within 12 months (a possible 311.90% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for scPharmaceuticals (SCPH)?
The latest analyst rating for scPharmaceuticals (NASDAQ:SCPH) was provided by HC Wainwright & Co., and scPharmaceuticals reiterated their buy rating.
When was the last upgrade for scPharmaceuticals (SCPH)?
The last upgrade for scPharmaceuticals Inc happened on October 11, 2022 when SVB Leerink raised their price target to $11. SVB Leerink previously had a market perform for scPharmaceuticals Inc.
When was the last downgrade for scPharmaceuticals (SCPH)?
There is no last downgrade for scPharmaceuticals.
When is the next analyst rating going to be posted or updated for scPharmaceuticals (SCPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of scPharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for scPharmaceuticals was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating scPharmaceuticals (SCPH) correct?
While ratings are subjective and will change, the latest scPharmaceuticals (SCPH) rating was a reiterated with a price target of $18.00 to $18.00. The current price scPharmaceuticals (SCPH) is trading at is $4.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.